ultiple neurologic disorders are thought to arise from dysfunctional neuronal circuits. Modulation of malfunctioning circuits can be achieved with therapies such as deep brain stimulation (DBS) (1). In DBS, electrical stimulation is delivered through implanted brain electrodes (2,3). DBS is best established as a therapeutic tool for movement disorders such as Parkinson disease, essential tremor, and dystonia (1,3). DBS is also being investigated as a treatment for psychiatric (4) and cognitive disorders (3). To date, more than 150 000 individuals have been implanted with DBS worldwide (5). Due to safety concerns, the ability to undergo MRI following DBS implantation is highly restricted. Because patients receiving DBS may require a wide range of MRI sequences for clinical purposes, and because MRI has been shown to be a valuable research tool in this population, additional data expounding the safety profile of MRI in individuals receiving DBS would be beneficial. Owing to safety concerns, MRI guidelines for scanning individuals receiving DBS are restrictive, largely limiting diagnostic uses. Strict safety guidelines (6-8) have been implemented after MRI-related adverse events (9): two cases of implantable pulse generator (IPG) failure during 1.5-T brain MRI; one case of temporary peri-electrode edema